Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Methylprednisolone hemisuccinate
Drug ID BADD_D01435
Description A water-soluble ester of methylprednisolone used for cardiac, allergic, and hypoxic emergencies.
Indications and Usage Adjunctive therapy for short-term administration in rheumatoid arthritis.
Marketing Status Prescription; Discontinued
ATC Code D07AA01; D10AA02; H02AB04
DrugBank ID DB14644
KEGG ID D05000
MeSH ID D008776
PubChem ID 16923
TTD Drug ID Not Available
NDC Product Code 57582-012; 24002-0015; 82298-109; 22552-0024; 52128-152
Synonyms Methylprednisolone Hemisuccinate | Hemisuccinate, Methylprednisolone | Methylprednisolone Succinate | Succinate, Methylprednisolone | Urbason-Soluble | UrbasonSoluble | Solu-Medrol | Solumedrol | A-MethaPred | Methylprednisolone Sodium Succinate | Sodium Succinate, Methylprednisolone | Methylprednisolone Hemisuccinate Monosodium Salt | 6 alpha-Methylprednisolone Sodium Hemisuccinate | Methylprednisolone Sodium Hemisuccinate | Sodium Hemisuccinate, Methylprednisolone
Chemical Information
Molecular Formula C26H34O8
CAS Registry Number 2921-57-5
SMILES CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)CCC(=O)O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Epstein-Barr virus infection11.05.10.0040.020984%
Erysipelas23.09.01.002; 11.02.06.0010.020984%Not Available
Erythema23.03.06.0010.279783%Not Available
Euphoric mood19.04.02.006--
Exophthalmos06.09.04.001; 05.02.02.002--Not Available
Extravasation08.01.03.0080.013989%Not Available
Eye pain06.08.03.0020.013989%
Eyelid oedema10.01.05.001; 06.04.04.004; 23.04.01.0030.048962%Not Available
Face oedema23.04.01.004; 10.01.05.002; 08.01.07.0030.055957%
Fatigue08.01.01.002--
Febrile neutropenia01.02.03.002; 08.05.02.004--
Feeling abnormal08.01.09.0140.069946%Not Available
Feeling cold08.01.09.0080.013989%Not Available
Feeling hot08.01.09.0090.069946%Not Available
Flatulence07.01.04.002--
Fluid retention20.01.02.003; 14.05.06.0020.034973%Not Available
Flushing24.03.01.002; 08.01.03.025; 23.06.05.0030.188853%
Folliculitis23.09.04.007; 11.01.12.0180.027978%
Fungal infection11.03.05.001--Not Available
Gait disturbance17.02.05.016; 08.01.02.002--
Gamma-glutamyltransferase increased13.03.01.0110.048962%
Gastric haemorrhage24.07.02.007; 07.12.01.001--
Gastric perforation12.02.03.007; 07.04.03.0010.013989%
Gastrooesophageal reflux disease07.02.02.003--
Gastrointestinal haemorrhage24.07.02.009; 07.12.02.0010.153881%Not Available
Gastrointestinal pain07.01.05.005--
Gastrointestinal perforation07.04.04.0010.003649%Not Available
Generalised tonic-clonic seizure17.12.01.002--Not Available
Glaucoma06.03.01.0020.020984%
Glucose tolerance impaired14.06.02.001; 05.06.02.001--
The 5th Page    First    Pre   5 6 7 8 9    Next   Last    Total 17 Pages